NextPlat Reports $65.5 Million in Consolidated Year-End 2024 Revenue
COCONUT GROVE, Fla., March 24, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce...
Month: March 2025
Aura Introduces AI-Powered Tools to Take on Youth Mental Health Crisis
New protections embrace connection over 'control,' giving parents deeper insights, tailored to each child, to help keep them safe, happy...
Avatar Medical Receives 510k Clearance for brAIn™ SPS brAIn™ SPS (Shoulder Positioning System) is to be Exclusively Utilized by FX Shoulder Solutions
ADDISON, Texas, March 24, 2025 /PRNewswire/ -- brAIn™ SPS was developed through a collaboration between Avatar Medical and FX Shoulder...
Abu Dhabi Gears Up to Host 25,000 Global Participants at AIM Congress in April
ABU DHABI, UAE, March 24, 2025 /PRNewswire/ -- The UAE capital, Abu Dhabi, is preparing to welcome over 25,000 participants, distinguished...
Brevel Expands Seed Round to US$25 Million Through Warrant Exercise
Microalgae protein innovator paves the path to cost parity with dual-tech processes KIRYAT GAT, Israel, March 24, 2025 /PRNewswire/ -- Climate...
InstantGMP PRO™ Now Available in Spanish, Expanding Compliance Solutions for Global Manufacturers
CARY, N.C., March 24, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of electronic batch record (EBR), manufacturing execution system (MES),...
Advanced Medical Balloons announces its new hygh-tec Odor Solution™ product, broadening its catheter portfolio
hygh-tec Odor Solution™ will be launched in Q2 2025FDA clearance and MDR certification already securedFirst generation hygh-tec™ catheter rapidly achieved more than...
Survey Projects High Turnover Rates Among Healthcare Executives in 2025
46% Plan to Leave Their Organizations in the Next 12 MonthsDALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Close to half...
PharmAla Contracts with Partner to Act as US Distributor
TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology...
PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, is pleased to announce that Annapath...
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
Company prioritizes ophthalmology pipeline programs with potential to provide new or improved treatment options in multiple severe and disabling eye...
Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol
The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel,...
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), (formerly Blue Water Biotech, Inc....
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) --...
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) --...
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose
Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last...
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference
SAN CLEMENTE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale...
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
MONTREAL, March 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF)...
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
Robust Evidence of Disease Reversal in Severe Knock Out Mice Model Supports Tenaya’s Clinical Development Plan to Evaluate TN-201 as...
Prostazen Ingredients Backed by Science: What You Should Know
LAKELAND, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- In the realm of men's health, particularly as they age, prostate health...